21-acetoxydeoxyscalarin - Compound Card

21-acetoxydeoxyscalarin

Select a section from the left sidebar

21-acetoxydeoxyscalarin

Structure
Zoomed Structure
  • Family: Animalia - Thorectidae
  • Kingdom: Animalia
  • Class: Terpenoid
    • Subclass: Scalarane-Type Sesterterpene
Canonical Smiles CC(=O)O[C@H]1[C@H]2[C@@](C)(CC[C@@H]3[C@]2(C)CCC[C@@]3(C)COC(=O)C)C[C@@H]2[C@@]1(C)C[C@H]1[C@H](O)OCC1=C2
InChI InChI=1S/C29H44O6/c1-17(30)34-16-27(4)9-7-10-28(5)22(27)8-11-26(3)13-20-12-19-15-33-25(32)21(19)14-29(20,6)24(23(26)28)35-18(2)31/h12,20-25,32H,7-11,13-16H2,1-6H3/t20-,21-,22+,23+,24+,25-,26+,27+,28+,29-/m1/s1
InChIKey OUSYQUBOSREUJU-HRJGVYIJSA-N
Formula C29H44O6
HBA 6
HBD 1
MW 488.67
Rotatable Bonds 3
TPSA 82.06
LogP 5.03
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 35
Formal Charge 0
Fraction CSP3 0.86
Exact Mass 488.31
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Hyrtios erecta Thorectidae Animalia 279628

Showing of synonyms

  • Youssef DT, Shaala LA, et al. (2005). Antimycobacterial scalarane-based sesterterpenes from the Red Sea sponge Hyrtios erecta. Journal of Natural Products,2005,68(12),1782-1784. [View] [PubMed]
Pubchem: 162939870
Nmrshiftdb2: 70044794

No compound-protein relationship available.

Structure

SMILES: C1OCC(C1=2)CC3C(C2)CC4C(C3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 488.67 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.93
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.8
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.35

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
1.48
Plasma Protein Binding
80.4
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
9.68
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.13
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.06
Liver Injury II
Toxic
hERG Blockers
Toxic
Daphnia Maga
6.74
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-277.32
Rat (Acute)
2.17
Rat (Chronic Oral)
2.01
Fathead Minnow
3.92
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
500.43
Hydration Free Energy
-2.98
Log(D) at pH=7.4
4.26
Log(P)
3.68
Log S
-5.79
Log(Vapor Pressure)
-8.76
Melting Point
200.88
pKa Acid
9.66
pKa Basic
5.72

No predicted protein targets found for this compound.

Download SDF